Clinical Trial Update: Immunogenicity and Safety Study of NBP615 in Healthy Female [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update on immunogenicity and safety of NBP615 in healthy female participants with completed status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• NBP615

Snippet

Sponsor: SK Bioscience Co., Ltd. | Conditions: Cervical Cancer | Phase 1, Phase 2 | Status: COMPLETED